Director of Stem Cell Transplant and Cellular Immunotherapy

Director, Stem Cell Transplant and Cellular Immunotherapy Program

The MedStar Georgetown University Hospital invites applications and nominations for the Director of Stem Cell Transplant and Cellular Therapy Program. As the only NCI-designated Comprehensive Cancer Center in Washington, D.C., MedStar Georgetown provides a unique opportunity for the incoming Director to lead and expand a program that benefits from three FACT-accredited programs: Bone Marrow Transplant (BMT), the nation’s largest Blood & Marrow Collection Program, and the Cell Therapy Manufacturing (CTMF) Lab, a gold-standard facility.

Location: Washington, DC
Hospital Appointment: MedStar Georgetown University Hospital
Cancer Network Affiliation: John Theurer Cancer Center / Regional Cancer Care Associates (RCCA)
Academic Affiliation: Georgetown University College of Medicine
Department: Hematology & Oncology

Washington, D.C., home to MedStar Georgetown University Hospital, offers an exceptional environment for medical professionals, combining world-class healthcare, research, and cultural richness.

Position Overview

MedStar Georgetown University Hospital is seeking a distinguished physician-scientist or clinical leader to serve as the Director of the Stem Cell Transplant and Cellular Immunotherapy Program. This is a leadership position within the Division of Hematology/Oncology, responsible for directing and expanding a world-class program in hematopoietic stem cell transplantation (HSCT) and cellular therapy. The successful candidate will oversee clinical operations, research initiatives, and faculty development, with a focus on innovation in transplantation, cellular immunotherapy, and precision medicine.

Key Responsibilities

• Provide strategic leadership in developing and expanding the Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital.
• Oversee the clinical operations of the stem cell transplant and immunotherapy service, ensuring high-quality patient care and adherence to national standards, including FACT and NMDP accreditation requirements.
• Lead clinical and translational research efforts focused on hematopoietic stem cell transplantation, CAR-T therapy, immune-based therapies, and novel cell-based approaches.
• Collaborate with institutional leadership to develop programmatic growth strategies, including recruitment of faculty, expansion of clinical trials, and implementation of innovative therapies.
• Foster collaborations with basic and translational scientists at Georgetown University’s Lombardi Comprehensive Cancer Center, as well as regional and national research networks.
• Serve as a mentor and educator for fellows, residents, and medical students, integrating cutting-edge advancements into education and training programs.
• Secure extramural funding and contribute to scholarly activities, including publishing in high-impact journals and presenting at national and international conferences.
• Partner with hospital administration and external stakeholders to enhance access to cellular immunotherapy, including expanding allogeneic and autologous transplant programs and CAR-T therapy initiatives.

Required Qualifications

• MD, MD/PhD, or equivalent degree with board certification in Hematology and/or Medical Oncology.
• Minimum 5 years of experience in hematopoietic stem cell transplantation and/or cellular immunotherapy with demonstrated leadership experience.
• Established record of clinical expertise, academic achievement, and research productivity in the field of stem cell transplantation and cellular immunotherapy.
• Eligible for faculty appointment at Georgetown University School of Medicine at the Associate Professor or Professor level.
• Proven ability to develop and lead multidisciplinary teams, foster collaborations, and build successful clinical and research programs.
• Experience with clinical trials, translational research, and securing extramural funding is highly desirable.
• Strong commitment to mentorship, education, and training of future leaders in hematology and cellular immunotherapy.

Lombardi Comprehensive Cancer Center (NCI-Designated)

The Georgetown Lombardi Comprehensive Cancer Center is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Washington, D.C. region, providing access to world-class cancer care, innovative clinical trials, and groundbreaking research. With more than 250 scientists and clinicians collaborating on translational and clinical research, Georgetown Lombardi is at the forefront of precision medicine and immunotherapy. The center’s extensive resources include state-of-the-art laboratories, cancer prevention programs, and partnerships with leading institutions worldwide. As part of Georgetown University Medical Center, an internationally recognized academic health and science center, it fulfills a four-part mission of research, teaching, service, and patient care. The center is led by Louis M. Weiner, MD.

Originally a small clinic for cancer patients, Georgetown Lombardi has grown into a state-of-the-art cancer center spanning over 240,000 square feet of clinic and research space. It became the 16th NCI-designated Comprehensive Cancer Center in the U.S. in 1974 and remains a leader in groundbreaking cancer research and treatment.

FACT-Accredited Programs at MedStar Georgetown University Hospital

The incoming Director will lead a program that is uniquely positioned to leverage three FACT-accredited programs that support groundbreaking research and patient care:

• Bone Marrow Transplant (BMT) Program: Recognized for excellence in hematopoietic stem cell transplantation, offering innovative treatment protocols for blood cancers and disorders.
• Blood & Marrow Collection Program: The largest in the country and the gold standard in donor stem cell collection, ensuring the highest quality standards in cellular therapy.
• Cell Therapy Manufacturing (CTMF) Lab: A cutting-edge facility dedicated to producing novel cell-based therapies, supporting research and clinical applications in immunotherapy and regenerative medicine.

These programs offer a robust foundation for clinical advancements, research collaboration, and expansion of cellular immunotherapy initiatives, positioning MedStar Georgetown as a leader in stem cell transplantation and cellular therapy.

The official logo of Georgetown University, a globally recognized institution known for its leadership in academics, research, and healthcare innovation.

Georgetown University School of Medicine

As one of the nation’s premier academic medical institutions, the Georgetown University School of Medicine has a rich tradition of excellence in medical education, biomedical research, and patient-centered care. With over 700 medical students and 1,200 faculty members, the school is committed to training future leaders in medicine while fostering an environment of discovery and innovation. The medical school’s strong emphasis on mentorship, ethics, and interdisciplinary collaboration provides an unparalleled foundation for faculty seeking to engage in academic medicine and research.

The newly opened Verstandig Pavilion at MedStar Georgetown University Hospital enhances patient care with 31 advanced operating rooms, 32 private emergency department rooms, and 156 private inpatient rooms. A testament to innovation in healthcare and medical research.

MedStar Georgetown University Hospital & MedStar Health System

MedStar Health is the largest healthcare provider in the Maryland-D.C. region, operating 10 hospitals, over 300 outpatient locations, and a comprehensive academic health system affiliated with Georgetown University. MedStar’s commitment to cutting-edge research, medical education, and advanced patient care makes it a leader in oncology, transplant medicine, and cellular immunotherapy. As part of MedStar Health, the Director of the Stem Cell Transplant and Cellular Immunotherapy Program will have access to vast clinical and research resources, a multidisciplinary network of specialists, and robust institutional support for program expansion.

Our centers of excellence include cancer care, neurosciences, gastroenterology, orthopedics, and transplant medicine. We are deeply committed to patient-centered care, research innovation, and associate satisfaction, fostering an inclusive environment where diverse perspectives lead to improved patient outcomes.

MedStar Georgetown University Hospital is one of the largest healthcare providers in the Washington, DC area and a premier academic medical center.

Key Institutional Highlights

• The only NCI-designated comprehensive cancer center (Georgetown Lombardi Comprehensive Cancer Center) in the Washington, D.C. region
• FACT Accreditation for Bone Marrow and Stem Cell Transplantation
• Magnet® Recognition recipient for nursing excellence (among only 1% of hospitals nationally to receive this designation five or more times)
• Home to one of the nation’s highest-volume transplant programs through the MedStar Georgetown Transplant Institute
• First hospital in the Washington, D.C. area to offer Proton Therapy
• Recently opened state-of-the-art Verstandig Pavilion featuring:
  • 487,400 square foot
  • 156 universal ICU and IMC patient rooms
  • 31-OR surgery suite, including Hybrid OR and 2 iMRI
  • 32 private Emergency Department rooms
  • 156 private patient rooms
  • Modern facilities designed for optimal patient care

Academic Excellence

• Academic and research affiliation with Georgetown University
• Robust medical residency programs
• AACN/Vizient Nurse Residency Program
• Ranked by U.S. News & World Report as one of the region’s best hospitals
• Recognized as “high performing” in multiple specialties and procedures
• Partnership with John Theurer Cancer Center & RCCA

The John Theurer Cancer Center, part of Hackensack University Medical Center and Hackensack Meridian Health, is a nationally recognized leader in bone marrow transplantation, CAR-T therapy, and cellular immunotherapy.

Partnership with John Theurer Cancer Center & RCCA

Through a strategic collaboration with the John Theurer Cancer Center (JTCC) and Regional Cancer Care Associates (RCCA), MedStar Georgetown enhances access to one of the most comprehensive hematologic malignancy and cellular therapy programs on the East Coast. JTCC is nationally recognized for its expertise in bone marrow transplantation, CAR-T therapy, and innovative immunotherapy approaches, treating over 6,000 patients annually. This partnership allows for shared clinical trials, expanded patient referral networks, and access to novel therapies, positioning MedStar Georgetown as a leader in transplant and cellular therapy.

Experience the beauty of Washington, D.C., with stunning cherry blossoms at the Jefferson Memorial, vibrant cultural landmarks, and an unparalleled quality of life.

Living in Washington, D.C., Maryland, and Northern Virginia

The Washington, D.C. metropolitan area offers an unparalleled combination of professional opportunities, cultural richness, and quality of life. Georgetown, located along the picturesque Potomac River, is known for its historic charm, vibrant arts scene, and world-class dining. The area provides easy access to Smithsonian museums, the Kennedy Center, and some of the nation’s top public and private schools. With three major airports, excellent public transportation, and proximity to the NIH, FDA, and top biotech hubs, D.C. is an ideal location for hematologist/oncologists seeking a balance between academic excellence and an enriching lifestyle. Whether enjoying outdoor activities along the Chesapeake Bay, exploring the scenic vineyards of Virginia wine country, or immersing in the region’s diverse cultural experiences, this is a prime destination for professionals and families alike.

Why Join MedStar Georgetown University Hospital?

MedStar Georgetown University Hospital is a leading academic medical center, home to the Lombardi Comprehensive Cancer Center, a National Cancer Institute (NCI)-designated cancer center. The institution is committed to groundbreaking research, outstanding patient care, and excellence in medical education.

As the Director of the Stem Cell Transplant and Cellular Immunotherapy Program, you will have the unique opportunity to shape the future of cellular therapy and immuno-oncology within a dynamic and supportive academic environment.

Join us in advancing the next frontier of hematologic malignancy treatment and cellular immunotherapy at MedStar Georgetown University Hospital.

Application Process

This search is being led by Academic Med, a retained executive search firm that specializes in physician and scientific leadership recruitment for academic health systems and cancer centers. Interested candidates should submit a CV and Cover Letter to Jim Hagood, Managing Director & Co-Founder of Academic Med via email: jim@academic-med.com

EEO
MedStar Georgetown University Hospital is an equal opportunity employer committed to fostering a diverse and inclusive workplace. We welcome applications from all qualified candidates, regardless of race, ethnicity, gender, sexual orientation, disability, veteran status, or any other protected characteristic. We believe that diversity strengthens our workforce and enhances patient care, and we are dedicated to creating an environment where all individuals have the opportunity to thrive.